OR WAIT null SECS
December 02, 2016
AstraZeneca entered a collaboration with Bicycle Therapeutics for the identification and development of bicyclic peptides.
November 30, 2016
Takeda will invest more than 100 million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.
November 29, 2016
Mylan signed a sub-license agreement with the Medicines Patent Pool to develop a generic version of daclatasvir to market in developing countries.
November 23, 2016
The acquisition boosts Allergan’s CNS R&D pipeline and adds development programs focused on treatment for Alzheimer’s disease.
November 22, 2016
Shire plans to establish a 550,000-square-foot campus that will focus on innovation in rare diseases and highly specialized conditions.
November 21, 2016
ESCMID has organized various activities to promote prudent use of antibiotics in Europe.
November 18, 2016
The company plans to expand access to its Prevanar 13 vaccine in humanitarian emergency settings.
November 17, 2016
Avecia is adding drug substance capacity at its Milford, MA manufacturing site.
November 15, 2016
Roche launched imCORE, a global network of cancer immunotherapy centers of excellence.
November 11, 2016
NIH researchers developed a test to identify existing drugs that might be able to combat drug-resistant bacteria.